Johnson & Johnson in preliminary talks to acquire Actelion

Friday, November 25, 2016 - 14:21 in Psychology & Sociology

Allen ConeALLSCHWIL, Switzerland, Nov. 25 (UPI) -- Johnson & Johnson, a U.S. healthcare giant, is in preliminary talks to acquire Actelion, a biopharmaceutical company in Swtizerland, both companies confirmed.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net